Bibiana Quirant-Sánchez

11PUBLICATIONS
41CO-AUTHORS
AutoimmunityPredictive and prognostic markersGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 08, 2025
Increased Risk of Myositis-Specific and Myositis-Associated Autoantibodies After COVID-19 Pandemic and Vaccination: A Spanish Multicenter Collaborative Study.

Laura García-Bravo, Alvaro Prada, María Gutiérrez Larrañaga

|Dec 09, 2024
SARS-CoV-2 Infection Risk by Vaccine Doses and Prior Infections Over 24 Months: ProHEpiC-19 Longitudinal Study.

Pere Torán-Monserrat, Noemí Lamonja-Vicente, Anna Costa-Garrido

|Dec 09, 2023
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.

Agustín Sancho-Saldaña, Anna Gil-Sánchez, Cristina González-Mingot

|Jul 27, 2022
Follow up of the Humoral Response in Healthcare Workers after the Administration of Two Dose of the Anti SARS-CoV-2 Vaccines-Effectiveness in Delta Variant Breakthrough Infections.

Gema Fernández-Rivas, Jaume Barallat, Bibiana Quirant-Sánchez

|May 14, 2022
Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.

Agustín Sancho-Saldaña, Anna Gil Sánchez, Bibiana Quirant-Sánchez

|Dec 24, 2021
Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis.

Bibiana Quirant-Sánchez, María José Mansilla, Juan Navarro-Barriuso

Pageof 2

Frequent Collaborators

4 joint publications

Cristina Ramo-Tello

2 joint publications

Ignacio Blanco

2 joint publications

Anna Gil-Sánchez

2 joint publications

Jaume Barallat